Stockscreener 앱 받기
5.45
10.51%
-0.64
시간 외 거래:
5.46
0.010
+0.18%
전일 마감가:
$6.09
열려 있는:
$6.12
하루 거래량:
37,898
Relative Volume:
0.58
시가총액:
$195.99M
수익:
-
순이익/손실:
$-25.50M
주가수익비율:
-7.0779
EPS:
-0.77
순현금흐름:
$-30.10M
1주 성능:
-2.85%
1개월 성능:
-6.84%
6개월 성능:
+36.08%
1년 성능:
+56.83%
1일 변동 폭
$5.35
$6.25
1주일 범위
$5.33
$6.25
52주 변동 폭
$2.6801
$7.19
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
EPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
5.45 | 308.13M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-26 | 개시 | H.C. Wainwright | Buy |
| 2025-06-16 | 개시 | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | 개시 | Craig Hallum | Buy |
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc 주식(EPRX)의 최신 뉴스
Eupraxia’s Trial Results Shine Despite Quarterly Losses - Finimize
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results - GlobeNewswire
Eupraxia (NASDAQ: EPRX) posts results; closes $80.5M offering, cash $89M - Stock Titan
Eupraxia Pharmaceuticals Releases Q3 2025 Financial Results - TipRanks
Volatility clustering patterns for Eupraxia Pharmaceuticals Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - newser.com
What MACD signals say about Eupraxia Pharmaceuticals Inc.Weekly Trade Review & Detailed Earnings Play Alerts - newser.com
Eupraxia Pharmaceuticals Inc. stock trend forecastWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Is Eupraxia Pharmaceuticals Inc. stock ready for a breakoutWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Is Eupraxia Pharmaceuticals Inc. stock bottoming outTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Why Eupraxia Pharmaceuticals Inc. stock is trending among retail tradersTrade Risk Report & Community Verified Swing Trade Signals - newser.com
Can Eupraxia Pharmaceuticals Inc. stock continue upward trendWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Will Eupraxia Pharmaceuticals Inc. (X43) stock outperform global peersMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Is Eupraxia Pharmaceuticals Inc. stock reversal real or fake2025 Trade Ideas & Safe Entry Momentum Stock Tips - newser.com
Using data filters to optimize entry into Eupraxia Pharmaceuticals Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Eupraxia Pharmaceuticals Inc. stock prediction for this weekPortfolio Growth Summary & Community Verified Trade Alerts - newser.com
(EPRX.WT.A) Stock Analysis and Trading Signals - news.stocktradersdaily.com
Will Eupraxia Pharmaceuticals Inc. stock see insider buyingWeekly Loss Report & Weekly Hot Stock Watchlists - newser.com
Is Eupraxia Pharmaceuticals Inc. reversing from oversold territoryNew Guidance & High Accuracy Trade Signal Alerts - newser.com
Regression analysis insights on Eupraxia Pharmaceuticals Inc. performanceJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
(EPRX) Stock Trading Blueprint (EPRX:CA) - news.stocktradersdaily.com
Research Analysts Offer Predictions for EPRX FY2025 Earnings - MarketBeat
Strategies to average down on Eupraxia Pharmaceuticals Inc.July 2025 Earnings & Reliable Trade Execution Plans - newser.com
Eupraxia Pharmaceuticals Inc. (EPRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to Strong-Buy at Leede Financial - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Expected to Announce Earnings on Thursday - MarketBeat
(EPRX.WT.A) Optimized Trading Opportunities - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. (EPRX.TO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Eupraxia Pharmaceuticals Advances EoE Treatment with EP-104GI Trial - TipRanks
This analyst loves Eupraxia Pharmaceuticals - Cantech Letter
(EPRX) Trading Strategy and Analysis (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc (EPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):